Holen Sie sich die Stockscreener-App
14.17
9.08%
1.18
Vorhandelsmarkt:
14.30
0.13
+0.92%
Finanzdaten der Trevi Therapeutics Inc-Aktie (TRVI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
19.63%
13.72
|
11.47 | 12.24 | 14.09 | 13.29 |
| Operating Income/Loss |
19.63%
-13.72
|
-11.47 | -12.24 | -14.09 | -13.29 |
| Nonoperating Income/Loss |
25.11%
1.40
|
1.119 | 0.844 | 0.814 | 0.929 |
| Income/Loss From Continuing Operations Before Tax |
19.04%
-12.32
|
-10.35 | -11.40 | -13.27 | -12.36 |
| Income Tax Expense/Benefit |
90.91%
-0.021
|
-0.011 | 0.016 | -0.031 | -0.008 |
| Income/Loss From Continuing Operations After Tax |
18.97%
-12.30
|
-10.34 | -11.41 | -13.24 | -12.35 |
|
Net Income/Loss
|
18.97%
-12.30
|
-10.34 | -11.41 | -13.24 | -12.35 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
10.83%
130.35
|
117.61 | 1.3558 | 101.28 | 101.04 |
| Diluted Average Shares |
10.83%
130.35
|
117.61 | 1.3558 | 101.28 | 101.04 |
| Basic Earnings Per Share |
0.00%
-0.09
|
-0.09 | -0.11 | -0.13 | -0.12 |
| Diluted Earnings Per Share |
0.00%
-0.09
|
-0.09 | -0.11 | -0.13 | -0.12 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):